Delhi HC sets aside Centre’s decision to ban 344 fixed dose combination medicines.

Delhi HC sets aside Centre's decision to ban 344 fixed dose combination medicines.

0
1220
Johnson Cherian.
In a major development and big relief to pharma majors, the Delhi High Court on Thursday set aside the Centre’s decision to ban 344 fixed dose combination (FDC) drugs, including well known names like Corex, a cough syrup, Vicks Action 500 and D’Cold.The Centre’s decision was challenged by Pfizer, Glenmark, Procter & Gamble, Cipla and some NGOs.
The government had prohibited manufacture, sale and distribution of 344 FDC drugs and issued a gazette notification to this effect on March 10. The Centre had contended these drugs had no ‘therapeutic justification’.

Share This:

Comments

comments